Skip to main content

Table 4 Survival by change in PG-SGA from T0 to T2

From: Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition

  N (%) Survival
Median (range)
Improved
 B to A 5 (7.7%) 652 (398–693)
 C to B 15 (23.1%) 311 (108–772)
Stayed the Same
 B to B 16 (24.6%) 452 (230–790)
 C to C 19 (29.2%) 162 (92–765)
 Declined
 B to C 10 (15.4%) 156 (92–376)
  1. PG-SGA Patient-generated subjective global assessment, Category A = well-nourished; Category B = suspected malnutrition or moderate malnutrition; Category C = severely malnourished; T0 = baseline, T2 = 90 days after the start of home parenteral nutrition